1.46
Finanzdaten der Treace Medical Concepts Inc-Aktie (TMCI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
24.51%
62.52
|
50.21 | 47.39 | 52.57 | 45.09 |
| Cost Of Revenue |
15.32%
12.12
|
10.51 | 9.635 | 10.68 | 8.954 |
| Gross Profit |
26.94%
50.40
|
39.71 | 37.75 | 41.89 | 36.13 |
|
|
1.70%
56.32
|
55.38 | 54.73 | 57.48 | 51.27 |
| Interest Income/Expense |
0.90%
1.35
|
1.338 | 1.321 | 1.311 | 1.313 |
| Benefits Costs and Expenses |
71.91
|
- | - | 68.49 | - |
| Costs And Expenses |
9.14%
71.91
|
65.89 | 64.36 | 68.49 | 60.22 |
| Operating Income/Loss |
62.22%
-5.922
|
-15.68 | -16.97 | -15.58 | -15.13 |
| Income/Loss From Continuing Operations Before Tax |
118.71%
-9.394
|
50.21 | -17.40 | -15.92 | 45.09 |
| Income/Loss From Continuing Operations After Tax |
42.33%
-9.394
|
-16.29 | -17.40 | -15.92 | -15.36 |
|
|
42.33%
-9.394
|
-16.29 | -17.40 | -15.92 | -15.36 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.69%
0.1992
|
63.52 | 63.01 | 62.66 | 62.23 |
| Diluted Average Shares |
99.69%
0.1992
|
63.52 | 63.01 | 62.66 | 62.23 |
| Basic Earnings Per Share |
46.15%
-0.14
|
-0.26 | -0.28 | -0.25 | -0.25 |
| Diluted Earnings Per Share |
46.15%
-0.14
|
-0.26 | -0.28 | -0.25 | -0.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):